<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab11">
 <label>Table 1.11</label>
 <caption>
  <p>Objectives for a vaccine</p>
 </caption>
 <table frame="hsides" rules="groups">
  <tbody>
   <tr>
    <td>1. Elicit a good humoral, cellular, and/or mucosal immune response that correlates with protection against clinical disease and reinfection</td>
   </tr>
   <tr>
    <td>2. Provide protection lasting at least several years and preferably a lifetime, similar to that induced by natural infection that leads to lifetime immunity</td>
   </tr>
   <tr>
    <td>3. Result in minimal immediate side effects or adverse reactions or mild disease and result in no delayed effects (e.g., late reactivation, CNS involvement, or cancer)</td>
   </tr>
   <tr>
    <td>4. Require a simple regimen for administration in a form and a schedule acceptable to the target population and the general public</td>
   </tr>
   <tr>
    <td>5. Pass a favorable cost/benefit analysis, where the health and economic benefit of administration clearly outweighs the cost and risk of natural disease and the adverse consequences of administration</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
